Tian Sheng Pharmaceutical announced its wholly-owned subsidiary, Hubei Tian Sheng Pharmaceutical, has passed the consistency evaluation for its Vitamin B6 Injection. This achievement marks a significant step for the company's future generic drug development and provides valuable experience. The company notes potential market and policy uncertainties for pharmaceutical products.
Summary generated by AI · Always verify with source document
Securities Code: 002872
Securities Abbreviation: ST Tian Sheng
Announcement Number: 2026-042
Tian Sheng Pharmaceutical Group Co., Ltd.
Announcement on Full Subsidiary's Vitamin B6 Injection Passing Generic Drug Consistency Evaluation
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false records, misleading statements, or significant omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.